Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Report

Global and Region Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：202
  • REPORT CODE：GMM956409
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Polycystic Ovarian Syndrome (PCOS) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Polycystic Ovarian Syndrome (PCOS) Therapeuticsmarket, defines the market attractiveness level of Polycystic Ovarian Syndrome (PCOS) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Polycystic Ovarian Syndrome (PCOS) Therapeutics industry, describes the types of Polycystic Ovarian Syndrome (PCOS) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Polycystic Ovarian Syndrome (PCOS) Therapeutics market and the development prospects and opportunities of Polycystic Ovarian Syndrome (PCOS) Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Polycystic Ovarian Syndrome (PCOS) Therapeutics market in Chapter 13.

    By Player:

    • Neurocrine Biosciences Inc

    • Merck KGaA

    • EffRx Inc

    • Crinetics Pharmaceuticals Inc

    • Novartis Pharmaceuticals

    • Bristol Myers Squibb

    • Sanofi Aventis

    • Pfizer Inc

    • Ferring Pharmaceuticals

    • Teva Pharmaceutical Industries Limited

    By Type:

    • Oral Contraceptive

    • Ovulation Inducing Agents

    • Facial Hair Growth Inhibitor

    • Insulin Sensitizing Agent

    By End-User:

    • Hospitals

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Polycystic Ovarian Syndrome (PCOS) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption (2017-2022)

    • 7.2 United States Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption (2017-2022)

    • 7.3 Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption (2017-2022)

    • 7.4 China Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption (2017-2022)

    • 7.5 Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption (2017-2022)

    • 7.6 India Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast (2022-2028)

    9 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Contraceptive Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Ovulation Inducing Agents Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Facial Hair Growth Inhibitor Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Insulin Sensitizing Agent Consumption and Growth Rate (2017-2022)

    • 9.2 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Ovulation Inducing Agents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Facial Hair Growth Inhibitor Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Insulin Sensitizing Agent Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Competitive Analysis

    • 14.1 Neurocrine Biosciences Inc

      • 14.1.1 Neurocrine Biosciences Inc Company Details

      • 14.1.2 Neurocrine Biosciences Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Neurocrine Biosciences Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • 14.2 Merck KGaA

      • 14.2.1 Merck KGaA Company Details

      • 14.2.2 Merck KGaA Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck KGaA Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • 14.3 EffRx Inc

      • 14.3.1 EffRx Inc Company Details

      • 14.3.2 EffRx Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 EffRx Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • 14.4 Crinetics Pharmaceuticals Inc

      • 14.4.1 Crinetics Pharmaceuticals Inc Company Details

      • 14.4.2 Crinetics Pharmaceuticals Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Crinetics Pharmaceuticals Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • 14.5 Novartis Pharmaceuticals

      • 14.5.1 Novartis Pharmaceuticals Company Details

      • 14.5.2 Novartis Pharmaceuticals Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novartis Pharmaceuticals Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • 14.6 Bristol Myers Squibb

      • 14.6.1 Bristol Myers Squibb Company Details

      • 14.6.2 Bristol Myers Squibb Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bristol Myers Squibb Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • 14.7 Sanofi Aventis

      • 14.7.1 Sanofi Aventis Company Details

      • 14.7.2 Sanofi Aventis Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi Aventis Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • 14.8 Pfizer Inc

      • 14.8.1 Pfizer Inc Company Details

      • 14.8.2 Pfizer Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • 14.9 Ferring Pharmaceuticals

      • 14.9.1 Ferring Pharmaceuticals Company Details

      • 14.9.2 Ferring Pharmaceuticals Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Ferring Pharmaceuticals Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • 14.10 Teva Pharmaceutical Industries Limited

      • 14.10.1 Teva Pharmaceutical Industries Limited Company Details

      • 14.10.2 Teva Pharmaceutical Industries Limited Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Teva Pharmaceutical Industries Limited Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Polycystic Ovarian Syndrome (PCOS) Therapeutics

    • Figure Polycystic Ovarian Syndrome (PCOS) Therapeutics Picture

    • Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption by Country (2017-2022)

    • Figure United States Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Polycystic Ovarian Syndrome (PCOS) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Contraceptive Consumption and Growth Rate (2017-2022)

    • Figure Global Ovulation Inducing Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Facial Hair Growth Inhibitor Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Sensitizing Agent Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Contraceptive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ovulation Inducing Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Facial Hair Growth Inhibitor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Sensitizing Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Neurocrine Biosciences Inc (Foundation Year, Company Profile and etc.)

    • Table Neurocrine Biosciences Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurocrine Biosciences Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • Table EffRx Inc (Foundation Year, Company Profile and etc.)

    • Table EffRx Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table EffRx Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • Table Crinetics Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Crinetics Pharmaceuticals Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Crinetics Pharmaceuticals Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • Table Novartis Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Novartis Pharmaceuticals Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Pharmaceuticals Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol Myers Squibb Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol Myers Squibb Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • Table Sanofi Aventis (Foundation Year, Company Profile and etc.)

    • Table Sanofi Aventis Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Aventis Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • Table Ferring Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Ferring Pharmaceuticals Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring Pharmaceuticals Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service

    • Table Teva Pharmaceutical Industries Limited (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Limited Polycystic Ovarian Syndrome (PCOS) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Limited Polycystic Ovarian Syndrome (PCOS) Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US